F2R anticorps (Coagulation Factor II (thrombin) Receptor)

Details for Product anti-F2R Antibody No. ABIN966804
Antigène
  • CF2R
  • HTR
  • PAR-1
  • PAR1
  • TR
  • Par1
  • TRGPC
  • AI482343
  • Cf2r
  • ThrR
  • Par-1
  • f2r-a
  • par1
  • coagulation factor II thrombin receptor
  • coagulation factor II (thrombin) receptor
  • coagulation factor 2 (thrombin) receptor L homeolog
  • F2R
  • F2r
  • f2r.L
Reactivité
Humain
168
33
32
3
2
2
2
2
2
1
Hôte
Souris
122
24
23
1
Clonalité (Clone)
Monoclonal ()
Conjugué
Cet anticorp F2R est non-conjugé
8
6
5
3
3
3
3
3
3
3
3
3
1
1
1
1
1
Application
ELISA, Western Blotting (WB)
121
85
23
22
13
10
9
6
6
3
2
1
1
1
Options
Immunogène Purified recombinant fragment of PAR1 expressed in E. Coli.
Clone 6A7H10
Isotype IgG1
Purification Ascitic fluid
Plasmids, Primers & others Plasmids, Primers & others F2R products on genomics-online (e.g. as negative or positive controls)
Antigène
Autre désignation PAR1 (F2R Antibody Extrait)
Sujet Synonyms: PAR1, D15S227E
ID gène 145624
Pathways Nuclear Receptor Transcription Pathway, Skeletal Muscle Fiber Development, Positive Regulation of Endopeptidase Activity, Protein targeting to Nucleus
Indications d'application Western Bloting: 1/500 - 1/2000.
ELISA: Propose dilution 1/10000.
Not yet tested in other applications.
Determining optimal working dilutions by titration test.
Restrictions For Research Use only
Format Liquid
Agent conservateur Sodium azide
Précaution d'utilisation This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock 4 °C
Produit citée dans: Tantivejkul, Loberg, Mawocha, Day, John, Pienta, Rubin, Pienta: "PAR1-mediated NFkappaB activation promotes survival of prostate cancer cells through a Bcl-xL-dependent mechanism." dans: Journal of cellular biochemistry, Vol. 96, Issue 3, pp. 641-52, 2005 (PubMed).

Background publications Heider, Schulze, Oswald, Henklein, Scheele, Kaufmann: "PAR1-type thrombin receptor stimulates migration and matrix adhesion of human colon carcinoma cells by a PKCepsilon-dependent mechanism." dans: Oncology research, Vol. 14, Issue 10, pp. 475-82, 2004 (PubMed).

Avez-vous cherché autre chose?